PACS Group Analyst Ratings
Citi Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $45
PACS Group Analyst Ratings
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating, Announces Target Price $44
Oppenheimer Maintains PACS Group(PACS.US) With Buy Rating, Maintains Target Price $40
Truist Securities Raises Price Target on PACS Group to $44 From $36, Maintains Buy Rating
A Quick Look at Today's Ratings for PACS Group(PACS.US), With a Forecast Between $40 to $41
A Quick Look at Today's Ratings for PACS Group(PACS.US), With a Forecast Between $40 to $41
PACS Group Inc (PACS) Receives a Buy From J.P. Morgan
Oppenheimer Adjusts PACS Group Price Target to $40 From $32, Maintains Outperform Rating
PACS Group Analyst Ratings
PACS Group Analyst Ratings
Truist Securities Maintains Buy on PACS Group, Raises Price Target to $36
PACS Group Analyst Ratings
Macquarie Initiates PACS at Outperform With $35 Price Target
Truist Financial Issues a Buy Rating on PACS Group Inc (PACS)
PACS Group Analyst Ratings
RBC Raises Price Target on PACS Group to $32 From $30, Keeps Outperform Rating
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (MGX), Smith Douglas Homes Corp. Class A (SDHC) and PACS Group Inc (PACS)
Analysts Are Bullish on Top NA Stocks: American Healthcare REIT, Inc. (AHR), PACS Group Inc (PACS)
No Data
No Data